Compare · CBLL vs ZIMVV
CBLL vs ZIMVV
Side-by-side comparison of CeriBell Inc. (CBLL) and ZimVie Inc. (ZIMVV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBLL and ZIMVV operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CBLL carries a market cap of $1.02B.
- CBLL has hit the wire 9 times in the past 4 weeks while ZIMVV has been quiet.
- CBLL has more recent analyst coverage (8 ratings vs 0 for ZIMVV).
- Company
- CeriBell Inc.
- ZimVie Inc.
- Price
- $26.15-0.85%
- -
- Market cap
- $1.02B
- -
- 1M return
- -5.42%
- -
- 1Y return
- +102.24%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 9
- 0
- Recent ratings
- 8
- 0
Latest CBLL
- Director Burke William W exercised 18,000 shares at a strike of $4.70 and sold $479,480 worth of shares (18,000 units at $26.64) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by CeriBell Inc.
- Director Taylor Joseph Michael sold $277,644 worth of shares (10,200 units at $27.22), decreasing direct ownership by 21% to 38,278 units (SEC Form 4)
- Chief Technology Officer Woo Raymond exercised 4,887 shares at a strike of $3.65 and sold $131,754 worth of shares (4,887 units at $26.96) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by CeriBell Inc.
- CeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ceribell Reports Third Quarter 2026 Financial Results
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026